Recently, OUE Group from Singapore and its partner institutions visited the Asian Venous Academy and Dr. Smile Medical Group Hong Kong for an in-depth exchange on international medical collaboration, specialist training, and the development of a CHIVA clinical education framework.

The visiting delegation brought together medical and management experts from OUE Healthcare, Lippo Group of Indonesia, and China Merchants Lippo Prince Bay Hospital in Shenzhen. Representatives from the participating institutions engaged in focused discussions on cross-border medical cooperation, clinical training models, academic exchange, and future collaboration in the field of venous medicine.

OUE Healthcare, the healthcare arm of OUE Group, operates hospitals, clinics, ambulatory surgical centers, and senior care facilities across China, Singapore, Japan, Indonesia, and other markets. Lippo Group has extensive experience in the operation and management of international integrated healthcare institutions. China Merchants Lippo Prince Bay Hospital, located in the Greater Bay Area, is dedicated to providing international-standard comprehensive medical services.

The three parties expressed strong interest in the academic exchange and technical collaboration planned with the Asian Venous Academy. Their participation reflects a shared commitment to promoting specialist development, enhancing clinical training, and strengthening regional medical cooperation.

As an academic platform based in Hong Kong and serving the broader Asian region, the Asian Venous Academy is deeply engaged in the field of venous disease. The Academy is committed to professional education, advanced academic research, and cross-regional medical collaboration. Through academic programs, clinical training, and specialist exchange, it aims to support the development of venous medicine and promote the dissemination of advanced clinical concepts and techniques across Asia.

This multi-party meeting established an important channel for long-term communication and collaboration. Moving forward, the participating institutions will continue to explore opportunities for deeper academic interaction, specialist experience sharing, and clinical training cooperation.

By connecting international healthcare resources with clinical expertise in venous medicine, the collaboration is expected to support medical education, clinical innovation, and international cooperation in the field of venous disease. It also marks another meaningful step in advancing the professional development and regional integration of venous medicine across Asia.